Ls of stat-1 and stat-3 signaling: An implication for the pathogenesis of arthritis. Arthritis Rheumatol. 2009, 60, 1451462. 32. Dai, X.; Sayama, K.; Tohyama, M.; Shirakata, Y.; Yang, L.; Hirakawa, S.; Tokumaru, S.; Hashimoto, K. The nf-kappab, p38 mapk and stat1 pathways differentially regulate the dsrna-mediated innate immune responses of epidermal keratinocytes. Int. Immunol. 2008, 20, 90109. 33. Fleetwood, A.J.; Dinh, H.; Cook, A.D.; Hertzog, P.J.; Hamilton, J.A. Gm-csf- and m-csf-dependent macrophage phenotypes display differential dependence on form i interferon signaling. J. Leukoc. Biol. 2009, 86, 41121. 34. Hardison, S.E.; Herrera, G.; Young, M.L.; Hole, C.R.; Wozniak, K.L.; Wormley, F.L., Jr. Protective immunity against pulmonary cryptococcosis is related to stat1-mediated classical macrophage activation. J. Immunol. 2012, 189, 4060068. 35. Tyagi, A.; Agarwal, C.; Dwyer-Nield, L.D.; Singh, R.P.; Malkinson, A.M.; Agarwal, R. Silibinin modulates tnf-alpha and ifn-gamma mediated signaling to regulate cox2 and inos expression in tumorigenic mouse lung epithelial lm2 cells. Mol. Carcinog. 2012, 51, 83242. 36. Kosaka, H.; Yoshimoto, T.; Fujimoto, J.; Nakanishi, K. Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat. Med. 2008, 14, 43741. 37. Eastabrook, G.D.; Hu, Y.; Tan, R.; Dutz, J.P.; Maccalman, C.D.; von Dadelszen, P. Decidual nk cell-derived conditioned medium (dnk-cm) mediates vegf-c secretion in extravillous cytotrophoblasts. Am. J. Reprod. Immunol. 2012, 67, 10111. 38. Hu, X.; Ivashkiv, L.B. Cross-regulation of signaling pathways by interferon-gamma: Implications for immune responses and autoimmune diseases. Immunity 2009, 31, 53950. 39. Schroder, K.; Sweet, M.J.; Hume, D.A. Signal integration between ifngamma and tlr signalling pathways in macrophages. Immunobiology 2006, 211, 51124. 40. Cagnin, S.; Biscuola, M.; Patuzzo, C.; Trabetti, E.; Pasquali, A.; Laveder, P.; Faggian, G.; Iafrancesco, M.; Mazzucco, A.; Pignatti, P.F.; et al. Reconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteries. BMC Genomics 2009, 10, 13. 41. Hansson, G.K. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1876890. 42. Poston, R.N.; Davies, D.F. Immunity and inflammation in the pathogenesis of atherosclerosis. A critique. Atherosclerosis 1974, 19, 35367.Int. J. Mol. Sci. 2014,43. Toshchakov, V.; Jones, B.W.; Perera, P.Y.; Thomas, K.; Cody, M.J.; Zhang, S.; Williams, B.R.; Key, J.; Hamilton, T.A.; Fenton, M.J.; et al. Tlr4, but not tlr2, mediates ifn-beta-induced stat1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 2002, three, 39298. 44. Clarke, D.L.; Clifford, R.L.; Jindarat, S.Psoralen ; Proud, D.Anti-Spike-RBD mAb ; Pang, L.PMID:28322188 ; Belvisi, M.; Knox, A.J. Tnfalpha and ifngamma synergistically enhance transcriptional activation of cxcl10 in human airway smooth muscle cells by way of stat-1, nf-kappab, plus the transcriptional coactivator creb-binding protein. J. Biol. Chem. 2010, 285, 291019110. 45. Qi, X.F.; Kim, D.H.; Yoon, Y.S.; Jin, D.; Huang, X.Z.; Li, J.H.; Deung, Y.K.; Lee, K.J. Essential involvement of cross-talk amongst ifn-gamma and tnf-alpha in cxcl10 production in human thp-1 monocytes. J. Cell. Physiol. 2009, 220, 69097. 46. Gao, J.; Morrison, D.C.; Parmely, T.J.; Russell, S.W.; Murphy, W.J. An interferon-gamma-activated internet site (gas) is necessary for complete expression of your mouse inos gene in response to interferon-gamma and li.